Status:
COMPLETED
Combining Default Choices and a Decision Aid to Improve Tobacco Cessation
Lead Sponsor:
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Collaborating Sponsors:
Tobacco Control Fund Switzerland
Swiss Medical Association (FMH)
Conditions:
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The FIRST cluster randomized trial will evaluate the effect of 1) a training program encouraging general practitioners to offer smoking cessation treatment as a default choice to all current smokers c...
Detailed Description
Smoking cessation medications are underused in primary care, likely because general practitioners (GP) lack detailed knowledge about prescribing and the fact that smokers seen in primary care must "op...
Eligibility Criteria
Inclusion
- Patient-level inclusion criteria:
- Consider the GP they are seeing in consultation to be their primary care doctor
- Use tobacco daily (cigarettes, cigars, smokeless tobacco)
- ≥18 years of age at the time of inclusion
- Patient-level exclusion criteria:
- Consulting for an urgent complaint that precludes even a brief discussion of smoking cessation
- Inability to follow the procedures of the study, e.g. unable to read French-language consent materials, severe psychiatric disorders, dementia, etc.
- Previous enrolment in a smoking cessation trial \<1 year prior
- Current daily user of a pharmacologic smoking cessation aid
- GP-level inclusion criteria:
- GP in private practice in French-speaking Switzerland (Vaud, Geneva, Jura, Neuchâtel, Fribourg or Valais) or metropolitan France
- Primarily French-speaking patients with \>80 individual patients seen in a typical month
- GP-level exclusion criteria:
- Completed an intensive smoking cessation curriculum \<2 years prior (ie. at least half-day of training)
- Have plans to retire or relocate outside of Switzerland or France in \<12 months
Exclusion
Key Trial Info
Start Date :
June 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2024
Estimated Enrollment :
287 Patients enrolled
Trial Details
Trial ID
NCT04868474
Start Date
June 15 2021
End Date
February 29 2024
Last Update
May 16 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Maison de santé Mermoz
Lyon, France
2
Unisante
Lausanne, Canton of Vaud, Switzerland, 1011